Glucocorticosteroids in Nano-Sterically Stabilized Liposomes Are Efficacious for Elimination of the Acute Symptoms of Experimental Cerebral Malaria
暂无分享,去创建一个
Yechezkel Barenholz | Haim Ovadia | Richard K. Haynes | J. Golenser | Y. Barenholz | H. Ovadia | S. Even-Chen | Lola Weiss | K. Turjeman | Jacob Golenser | Judith H. Waknine-Grinberg | Simcha Even-Chen | Jasmine Avichzer | Keren Turjeman | Annael Bentura-Marciano | Nahum Allon | R. Haynes | L. Weiss | N. Allon | Jasmine Avichzer | Annael Bentura-Marciano
[1] L. Adorini,et al. Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes. , 2000, Immunology today.
[2] G. Grau,et al. Pathogenesis of Cerebral Malaria: Recent Experimental Data and Possible Applications for Humans , 2001, Clinical Microbiology Reviews.
[3] Milos Pekny,et al. Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury , 2006, Proceedings of the National Academy of Sciences.
[4] Caroline Rae,et al. Immunopathogenesis of cerebral malaria. , 2006, International journal for parasitology.
[5] J. Breman. Resistance to artemisinin-based combination therapy. , 2012, The Lancet. Infectious diseases.
[6] Kamolrat Silamut,et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial , 2010, The Lancet.
[7] D. Dorward,et al. Middleton’s Allergy: Principles and Practice , 2013 .
[8] T. Efferth,et al. Toxicity of the antimalarial artemisinin and its dervatives , 2010, Critical reviews in toxicology.
[9] Shailesh Singh,et al. The cerebral-malaria-associated expression of RANTES, CCR3 and CCR5 in post-mortem tissue samples , 2004, Annals of tropical medicine and parasitology.
[10] A. Tager,et al. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria , 2008, Proceedings of the National Academy of Sciences.
[11] A. Adegnika,et al. In vitro activity of artemisone compared with artesunate against Plasmodium falciparum. , 2006, The American journal of tropical medicine and hygiene.
[12] M. Wahlgren,et al. Molecular aspects of malaria pathogenesis. , 2004, FEMS immunology and medical microbiology.
[13] Y. Barenholz. Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[14] C. Epstein,et al. Attenuation of acute and chronic damage following traumatic brain injury in copper, zinc-superoxide dismutase transgenic mice. , 1996, Journal of neurosurgery.
[15] J. Frangos,et al. Efficacy of Different Nitric Oxide-Based Strategies in Preventing Experimental Cerebral Malaria by Plasmodium berghei ANKA , 2012, PloS one.
[16] N. Hunt,et al. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. , 2003, Trends in immunology.
[17] T. Chan-Ling,et al. Quantitation of brain edema and localisation of aquaporin 4 expression in relation to susceptibility to experimental cerebral malaria. , 2011, International journal of clinical and experimental pathology.
[18] L. Rénia,et al. Control of pathogenic CD8+ T cell migration to the brain by IFN‐γ during experimental cerebral malaria , 2008, Parasite immunology.
[19] Frieder Keller,et al. Pharmacokinetics and Pharmacodynamics of Systemically Administered Glucocorticoids , 2005, Clinical Pharmacokinetics.
[20] P. Moynagh. The interleukin‐1 signalling pathway in astrocytes: a key contributor to inflammation in the brain , 2005, Journal of anatomy.
[21] G. Enwere. A review of the quality of randomized clinical trials of adjunctive therapy for the treatment of cerebral malaria , 2005, Tropical medicine & international health : TM & IH.
[22] S. Croft,et al. Artemisone--a highly active antimalarial drug of the artemisinin class. , 2006, Angewandte Chemie.
[23] R. J. Doerksen,et al. Structure-activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinflammation and cerebral infections. , 2010, Journal of medicinal chemistry.
[24] Y. Tettey,et al. High-level cerebellar expression of cytokines and adhesion molecules in fatal, paediatric, cerebral malaria , 2005, Annals of tropical medicine and parasitology.
[25] S. Hoffman,et al. High-dose dexamethasone in quinine-treated patients with cerebral malaria: a double-blind, placebo-controlled trial. , 1988, The Journal of infectious diseases.
[26] I. Elenkov. Glucocorticoids and the Th1/Th2 Balance , 2004, Annals of the New York Academy of Sciences.
[27] Yan Ding,et al. Comparative Histopathology of Mice Infected With the 17XL and 17XNL Strains of Plasmodium yoelii , 2012, The Journal of parasitology.
[28] J. Frangos,et al. Immunopathology and Infectious Diseases Murine Cerebral Malaria Is Associated with a Vasospasm-Like Microcirculatory Dysfunction , and Survival upon Rescue Treatment Is Markedly Increased by Nimodipine , 2010 .
[29] H. Ball,et al. Chemokine Gene Expression during Fatal Murine Cerebral Malaria and Protection Due to CXCR3 Deficiency1 , 2008, The Journal of Immunology.
[30] M. Bell,et al. Microglia and inflammation: impact on developmental brain injuries. , 2006, Mental retardation and developmental disabilities research reviews.
[31] Middleton's Allergy: Principles and Practice: Eighth Edition , 2013 .
[32] A. Sigal,et al. Pegylated nanoliposomes remote-loaded with the antioxidant tempamine ameliorate experimental autoimmune encephalomyelitis , 2009, Journal of Neuroimmunology.
[33] Charity W. Law,et al. Effective Adjunctive Therapy by an Innate Defense Regulatory Peptide in a Preclinical Model of Severe Malaria , 2012, Science Translational Medicine.
[34] F. Amante,et al. High Parasite Burdens Cause Liver Damage in Mice following Plasmodium berghei ANKA Infection Independently of CD8+ T Cell-Mediated Immune Pathology , 2011, Infection and Immunity.
[35] R. Swanson,et al. Microglial activation induced by brain trauma is suppressed by post-injury treatment with a PARP inhibitor , 2012, Journal of Neuroinflammation.
[36] D. Warrell,et al. Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. , 1982, The New England journal of medicine.
[37] H. Ball,et al. Perforin mediated apoptosis of cerebral microvascular endothelial cells during experimental cerebral malaria. , 2006, International journal for parasitology.
[38] Yechezkel Barenholz,et al. Fabrication Principles and Their Contribution to the Superior In Vivo Therapeutic Efficacy of Nano-Liposomes Remote Loaded with Glucocorticoids , 2011, PloS one.
[39] I. Campbell,et al. Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity – a tale of conflict and conundrum , 2010, Neuropathology and applied neurobiology.
[40] M. Stins,et al. How can microbial interactions with the blood–brain barrier modulate astroglial and neuronal function? , 2011, Cellular microbiology.
[41] P. Hellewell,et al. Regulation of ICAM-1 by dexamethasone in a human vascular endothelial cell line EAhy926. , 1996, The American journal of physiology.
[42] D. Hommes,et al. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands , 2008, Steroids.
[43] H. M. Sonawat,et al. Multivariate modelling with 1H NMR of pleural effusion in murine cerebral malaria , 2011, Malaria Journal.
[44] J. Dietrich. The adhesion molecule ICAM-1 and its regulation in relation with the blood–brain barrier , 2002, Journal of Neuroimmunology.
[45] M. D. Smith. High-performance liquid chromatographic determination of hydrocortisone and methylprednisolone and their hemisuccinate esters in human serum. , 1979, Journal of chromatography.
[46] K. Prasad,et al. Steroids for treating cerebral malaria. , 1999, The Cochrane database of systematic reviews.
[47] T. Chan-Ling,et al. Reactive changes of retinal microglia during fatal murine cerebral malaria: effects of dexamethasone and experimental permeabilization of the blood-brain barrier. , 2000, The American journal of pathology.
[48] E. Riley,et al. Heterogeneous and Tissue-Specific Regulation of Effector T Cell Responses by IFN-γ during Plasmodium berghei ANKA Infection , 2011, The Journal of Immunology.
[49] A. Salmaggi,et al. High-Dose Methylprednisolone Reduces Cytokine-Induced Adhesion Molecules on Human Brain Endothelium , 2000, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[50] W. Backer,et al. Glucocorticosteroids as antioxidants in treatment of asthma and COPD New application for an old medication? , 2007, Steroids.
[51] P. Dore‐Duffy,et al. FLUIDS AND BARRIERS OF THE CNS REVIEW Open Access The CNS microvascular pericyte: pericyte-astrocyte crosstalk in the regulation of tissue survival , 2022 .
[52] Alexander Golbraikh,et al. Quantitative structure-property relationship modeling of remote liposome loading of drugs. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[53] T. Chan-Ling,et al. Redistribution and degeneration of retinal astrocytes in experimental murine cerebral malaria: Relationship to disruption of the blood‐retinal barrier , 1996, Glia.
[54] J. Frangos,et al. Artemether and Artesunate Show the Highest Efficacies in Rescuing Mice with Late-Stage Cerebral Malaria and Rapidly Decrease Leukocyte Accumulation in the Brain , 2011, Antimicrobial Agents and Chemotherapy.
[55] G. Schmuck,et al. Developmental and reproductive toxicity studies on artemisone. , 2009, Birth defects research. Part B, Developmental and reproductive toxicology.
[56] I. Rogatsky,et al. Minireview: Glucocorticoids in autoimmunity: unexpected targets and mechanisms. , 2011, Molecular endocrinology.
[57] L. Steinman,et al. Multiple sclerosis: trapped in deadly glue , 2005, Nature Medicine.
[58] J. Quevedo,et al. Cognitive Dysfunction Is Sustained after Rescue Therapy in Experimental Cerebral Malaria, and Is Reduced by Additive Antioxidant Therapy , 2010, PLoS pathogens.
[59] B. Ryffel,et al. Role of ICAM-1 (CD54) in the development of murine cerebral malaria. , 1999, Microbes and infection.
[60] D. Sullivan,et al. Plasmodium falciparum-infected erythrocytes induce NF-kappaB regulated inflammatory pathways in human cerebral endothelium. , 2009, Blood.
[61] A. Dash,et al. CXCL4 and CXCL10 Predict Risk of Fatal Cerebral Malaria , 2011, Disease markers.
[62] Y. Barenholz,et al. Optimization of vincristine-topotecan combination--paving the way for improved chemotherapy regimens by nanoliposomes. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[63] F. Ginhoux,et al. CD8+ T Cells and IFN-γ Mediate the Time-Dependent Accumulation of Infected Red Blood Cells in Deep Organs during Experimental Cerebral Malaria , 2011, PloS one.
[64] M. Rachid,et al. Improving cognitive outcome in cerebral malaria: insights from clinical and experimental research. , 2011, Central nervous system agents in medicinal chemistry.
[65] E. Dubois. Clinical Potencies of Glucocorticoids: What do we Really Measure? , 2005 .
[66] Y. Barenholz,et al. Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer. , 2005, Chemistry and physics of lipids.